@article{f6046d36e5634aa9912ed5a2d46defaf,
title = "3D-Printed Micro Lens-in-Lens for In Vivo Multimodal Microendoscopy",
abstract = "Multimodal microendoscopes enable co-located structural and molecular measurements in vivo, thus providing useful insights into the pathological changes associated with disease. However, different optical imaging modalities often have conflicting optical requirements for optimal lens design. For example, a high numerical aperture (NA) lens is needed to realize high-sensitivity fluorescence measurements. In contrast, optical coherence tomography (OCT) demands a low NA to achieve a large depth of focus. These competing requirements present a significant challenge in the design and fabrication of miniaturized imaging probes that are capable of supporting high-quality multiple modalities simultaneously. An optical design is demonstrated which uses two-photon 3D printing to create a miniaturized lens that is simultaneously optimized for these conflicting imaging modalities. The lens-in-lens design contains distinct but connected optical surfaces that separately address the needs of both fluorescence and OCT imaging within a lens of 330 µm diameter. This design shows an improvement in fluorescence sensitivity of >10x in contrast to more conventional fiber-optic design approaches. This lens-in-lens is then integrated into an intravascular catheter probe with a diameter of 520 µm. The first simultaneous intravascular OCT and fluorescence imaging of a mouse artery in vivo is reported.",
keywords = "3D printing, multimodal imaging, near infrared fluorescence, optical coherence tomography, two-photon laser lithography",
author = "Jiawen Li and Simon Thiele and Kirk, {Rodney W.} and Quirk, {Bryden C.} and Ayla Hoogendoorn and Chen, {Yung Chih} and Karlheinz Peter and Nicholls, {Stephen J.} and Verjans, {Johan W.} and Psaltis, {Peter J.} and Christina Bursill and Herkommer, {Alois M.} and Harald Giessen and McLaughlin, {Robert A.}",
note = "Funding Information: The authors acknowledge National Health and Medical Research Council (NHMRC) Ideas Grant (APP2001646 and APP2002254), the Australian Research Council (CE140100003), BMBF PRINTOPTICS (13N14096, 13N14097) and QR.X, Baden-W?rttemberg (BW) Stiftung OPTERIAL, European Research Council Advanced Grant COMPLEXPLAS, European Research Council Proof of Concept 3D Printed Optics, German Research Foundation (DFG), Integrated quantum science and technology (IQST), and Australia-Germany Joint Research Co-operation Scheme (UA-DAAD). University of Stuttgart Terra Incognita Fund. J.L. was the recipient of Fellowships from National Heart Foundation of Australia (102093 and 105608) and NHMRC Investigator EL1 Fellowship (GNT2008462). A.H. was the recipient of a Netherlands Heart Institute Fellowship (2018). Y.C.C. was the recipient of a Future Leader Fellowship from the National Heart Foundation of Australia (102068). K.P. was the recipient of a NHMRC Investigator L3 Fellowship (GNT1174098). S.J.N. was the recipient of a NHMRC Principal Research Fellowship (1111630). C.A.B. was the recipient of Lin Huddleston Senior Fellowship from the National Heart Foundation of Australia. C.A.B. and R.A.M. acknowledge NHMRC Development Grant (APP1178912). P.J.P. was the recipient of a Future Leader Fellowship from the National Heart Foundation of Australia (FLF102056) and a Career Development Fellowship from the NHMRC (CDF1161506). Funding Information: The authors acknowledge National Health and Medical Research Council (NHMRC) Ideas Grant (APP2001646 and APP2002254), the Australian Research Council (CE140100003), BMBF PRINTOPTICS (13N14096, 13N14097) and QR.X, Baden‐W{\"u}rttemberg (BW) Stiftung OPTERIAL, European Research Council Advanced Grant COMPLEXPLAS, European Research Council Proof of Concept 3D Printed Optics, German Research Foundation (DFG), Integrated quantum science and technology (IQST), and Australia‐Germany Joint Research Co‐operation Scheme (UA‐DAAD). University of Stuttgart Terra Incognita Fund. J.L. was the recipient of Fellowships from National Heart Foundation of Australia (102093 and 105608) and NHMRC Investigator EL1 Fellowship (GNT2008462). A.H. was the recipient of a Netherlands Heart Institute Fellowship (2018). Y.C.C. was the recipient of a Future Leader Fellowship from the National Heart Foundation of Australia (102068). K.P. was the recipient of a NHMRC Investigator L3 Fellowship (GNT1174098). S.J.N. was the recipient of a NHMRC Principal Research Fellowship (1111630). C.A.B. was the recipient of Lin Huddleston Senior Fellowship from the National Heart Foundation of Australia. C.A.B. and R.A.M. acknowledge NHMRC Development Grant (APP1178912). P.J.P. was the recipient of a Future Leader Fellowship from the National Heart Foundation of Australia (FLF102056) and a Career Development Fellowship from the NHMRC (CDF1161506). Funding Information: Y.C.C. and K.P. are inventors on a patent describing NIRAF for the detection of high‐risk, rupture‐prone atherosclerotic plaques. K.P. is the chief medical officer of NIRTEK. R.W.K., B.C.Q., and R.A.M. are co‐founders and directors of Miniprobes Pty Ltd., a company that develops novel optical imaging systems. Miniprobes Pty Ltd. did not contribute to this study. S.J.N. has received research support from AstraZeneca, Amgen, Anthera, CSL Behring, Cerenis, Eli Lilly, Esperion, Resverlogix, Novartis, InfraReDx, and Sanofi‐Regeneron and is a consultant for Amgen, Akcea, AstraZeneca, Boehringer Ingelheim, CSL Behring, Eli Lilly, Esperion, Kowa, Merck, Takeda, Pfizer, Sanofi‐Regeneron, and Novo Nordisk. P.J.P. has received research support from Abbott Vascular, consulting fees from Amgen and Esperion and speaker honoraria from AstraZeneca, Bayer, Boehringer Ingelheim, Merck Schering‐Plough, and Pfizer. Publisher Copyright: {\textcopyright} 2022 The Authors. Small published by Wiley-VCH GmbH.",
year = "2022",
month = apr,
day = "27",
doi = "10.1002/smll.202107032",
language = "English",
volume = "18",
journal = "Small",
issn = "1613-6810",
publisher = "Wiley-VCH Verlag GmbH & Co. KGaA",
number = "17",
}